Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Ephedrine Market Size Growth Rate by Type
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Injection
1.4 Market Segment by Application
1.4.1 Global Ephedrine Market Share by Application (2019-2025)
1.4.2 Medical use
1.4.3 Recreational use
1.4.4 Other uses
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ephedrine Market Size
2.1.1 Global Ephedrine Revenue 2014-2025
2.1.2 Global Ephedrine Sales 2014-2025
2.2 Ephedrine Growth Rate by Regions
2.2.1 Global Ephedrine Sales by Regions 2014-2019
2.2.2 Global Ephedrine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Ephedrine Sales by Manufacturers
3.1.1 Ephedrine Sales by Manufacturers 2014-2019
3.1.2 Ephedrine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Ephedrine Revenue by Manufacturers (2014-2019)
3.2.2 Ephedrine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Ephedrine Market Concentration Ratio (CR5 and HHI)
3.3 Ephedrine Price by Manufacturers
3.4 Key Manufacturers Ephedrine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Ephedrine Market
3.6 Key Manufacturers Ephedrine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Tablet Sales and Revenue (2014-2019)
4.1.2 Capsule Sales and Revenue (2014-2019)
4.1.3 Injection Sales and Revenue (2014-2019)
4.2 Global Ephedrine Sales Market Share by Type
4.3 Global Ephedrine Revenue Market Share by Type
4.4 Ephedrine Price by Type
5 Market Size by Application
5.1 Overview
5.1 Global Ephedrine Sales by Application
6 North America
6.1 North America Ephedrine Breakdown Data by Company
6.2 North America Ephedrine Breakdown Data by Type
6.3 North America Ephedrine Breakdown Data by Application
6.4 North America Ephedrine Breakdown Data by Countries
6.4.1 North America Ephedrine Sales by Countries
6.4.2 North America Ephedrine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Ephedrine Breakdown Data by Company
7.2 Europe Ephedrine Breakdown Data by Type
7.3 Europe Ephedrine Breakdown Data by Application
7.4 Europe Ephedrine Breakdown Data by Countries
7.4.1 Europe Ephedrine Sales by Countries
7.4.2 Europe Ephedrine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ephedrine Breakdown Data by Company
8.2 Asia Pacific Ephedrine Breakdown Data by Type
8.3 Asia Pacific Ephedrine Breakdown Data by Application
8.4 Asia Pacific Ephedrine Breakdown Data by Regions
8.4.1 Asia Pacific Ephedrine Sales by Countries
8.4.2 Asia Pacific Ephedrine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Ephedrine Breakdown Data by Company
9.2 Central & South America Ephedrine Breakdown Data by Type
9.3 Central & South America Ephedrine Breakdown Data by Application
9.4 Central & South America Ephedrine Breakdown Data by Countries
9.4.1 Central & South America Ephedrine Sales by Countries
9.4.2 Central & South America Ephedrine Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Ephedrine Breakdown Data by Type
10.2 Middle East and Africa Ephedrine Breakdown Data by Application
10.3 Middle East and Africa Ephedrine Breakdown Data by Countries
10.3.1 Middle East and Africa Ephedrine Sales by Countries
10.3.2 Middle East and Africa Ephedrine Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Ephedrine
11.1.4 Ephedrine Product Introduction
11.1.5 Pfizer Recent Development
11.2 Servier
11.2.1 Servier Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Ephedrine
11.2.4 Ephedrine Product Introduction
11.2.5 Servier Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Ephedrine
11.3.4 Ephedrine Product Introduction
11.3.5 Roche Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Ephedrine
11.4.4 Ephedrine Product Introduction
11.4.5 Merck Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Ephedrine
11.5.4 Ephedrine Product Introduction
11.5.5 Amgen Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Ephedrine
11.6.4 Ephedrine Product Introduction
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Ephedrine
11.7.4 Ephedrine Product Introduction
11.7.5 Sanofi Recent Development
11.8 Medarex
11.8.1 Medarex Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Ephedrine
11.8.4 Ephedrine Product Introduction
11.8.5 Medarex Recent Development
11.9 Malladi Drugs&Pharmaceuticals
11.9.1 Malladi Drugs&Pharmaceuticals Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Ephedrine
11.9.4 Ephedrine Product Introduction
11.9.5 Malladi Drugs&Pharmaceuticals Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Ephedrine
11.10.4 Ephedrine Product Introduction
11.10.5 GlaxoSmithKline Recent Development
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Ephedrine Sales Channels
12.2.2 Ephedrine Distributors
12.3 Ephedrine Customers
13 Market Forecast
13.1 Global Ephedrine Sales and Revenue Forecast 2019-2025
13.2 Global Ephedrine Sales Forecast by Type
13.3 Global Ephedrine Sales Forecast by Application
13.4 Ephedrine Forecast by Regions
13.4.1 Global Ephedrine Sales Forecast by Regions 2019-2025
13.4.2 Global Ephedrine Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Ephedrine Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Ephedrine Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Ephedrine Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Ephedrine Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Ephedrine Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Pfizer、Servier、Roche、Merck、Amgen、Novartis、Sanofi、Medarex、Malladi Drugs&Pharmaceuticals、GlaxoSmithKline